Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2015 1
2017 1
2019 1
2020 1
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Mitochondrial SIRT3 and neurodegenerative brain disorders.
Anamika, Khanna A, Acharjee P, Acharjee A, Trigun SK. Anamika, et al. Among authors: acharjee a. J Chem Neuroanat. 2019 Jan;95:43-53. doi: 10.1016/j.jchemneu.2017.11.009. Epub 2017 Nov 9. J Chem Neuroanat. 2019. PMID: 29129747 Review.
Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential.
Suvarna K, Biswas D, Pai MGJ, Acharjee A, Bankar R, Palanivel V, Salkar A, Verma A, Mukherjee A, Choudhury M, Ghantasala S, Ghosh S, Singh A, Banerjee A, Badaya A, Bihani S, Loya G, Mantri K, Burli A, Roy J, Srivastava A, Agrawal S, Shrivastav O, Shastri J, Srivastava S. Suvarna K, et al. Among authors: acharjee a. Front Physiol. 2021 Apr 27;12:652799. doi: 10.3389/fphys.2021.652799. eCollection 2021. Front Physiol. 2021. PMID: 33995121 Free PMC article.
Rise of the SARS-CoV-2 Variants: can proteomics be the silver bullet?
Acharjee A, Stephen Kingsly J, Kamat M, Kurlawala V, Chakraborty A, Vyas P, Vaishnav R, Srivastava S. Acharjee A, et al. Expert Rev Proteomics. 2022 Jun 20:1-16. doi: 10.1080/14789450.2022.2085564. Online ahead of print. Expert Rev Proteomics. 2022. PMID: 35655386